4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001608936-25-000008
PRESIDENT AND CEO sold 87,539 shares at an average $12.04 ($1,053,555)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chacko Jacob PRESIDENT AND CEO | 2025-09-30 | Sale 10b5-1 | −34,538 | $12.01 | $414,750 | 621,881 | D |
| Chacko Jacob PRESIDENT AND CEO | 2025-10-01 | Sale 10b5-1 | −53,001 | $12.05 | $638,805 | 568,880 | D |
| Open-market sales · 87,539 sh · avg $12.04 · $1,053,555 | |||||||
Loading xslF345X05/form4-10022025_111028.xml…